Najlepsi lekarze na świecie

Dr Sangkyu Park jest doświadczonym neurochirurgiem z ponad 18-letnim doświadczeniem w tej dziedzinie, specjalizującym się w chorobach naczyń mózgowych, tętniakach mózgu i innych pokrewnych schorzeniach. Ukończył Hanyang University College of Medicine w 2003 r., uzyskał tytuł magistra i doktora w Graduate School of Medicine i jest członkiem różnych stowarzyszeń medycznych. Jest autorem rozdziałów książek i publikował w wielu czasopismach krajowych i międzynarodowych.

Dr. Aleix Prat is a clinical scientist with expertise in breast cancer research, gene expression, and clinical trials. He earned his MD from the University of Barcelona. He completed his oncology fellowship at Vall d’Hebron Institute of Oncology. Dr. Prat leads the Translational Genomics and Targeted Therapeutics in Solid Tumors Group at IDIBAPS. He is also President of SOLTI and serves on the Executive Committee of The Breast International Group.

Dr. Prat has published over 160 scientific papers. His work has received 13,479 citations, and he has an H-Index of 51. He is a Tenure-Track Professor at the University of Barcelona. He also directs the Breast Pathology–Senology Master’s degree. His roles highlight his strong academic and clinical contributions to oncology.

Dr. Ana Oaknin is a Medical Oncologist with expertise in angiogenesis, DNA repair, and immunology. She focuses on gynecological cancers. Dr. Oaknin earned her medical degree and MD in Medical Oncology from Complutense University of Madrid. She also holds a PhD from Universidad Autonoma de Barcelona.

Dr. Oaknin is Co-Chair of the GEICO Group. She is a faculty member for the Gyn-Track in the European Society of Medical Oncology. She represents Spain in the GOG and GCIG committees. Dr. Oaknin is an active member of ASCO, ESMO, and SEOM. She has published over 100 scientific articles and presentations. She also leads several clinical trials in ovarian, cervical, and endometrial cancer.

Dr. Francesc Bosch is an expert in Chronic Lymphocytic Leukemia (CLL) and lymphomas. He leads research in the molecular causes and new treatments for CLL and other lymphoproliferative disorders.

He has published over 100 articles in leading journals, including The New England Journal of Medicine and Nature Medicine. Dr. Bosch oversees more than 80 clinical studies, from phase 1 to phase 3, and plays a key role in developing new drugs.

He is the Head of Hematology at Vall d’Hebron University Hospital and IOB Institute of Oncology. He also serves as president of GELLC and is a professor of hematology. His work has improved diagnosis and treatment for blood diseases.

Neurochirurg kręgosłupa

Onkoginekolog, specjalista operacji laparoskopowych

Neurolog

Profesor specjalizujący się w laparoskopowych operacjach jelit, leczeniu raka odbytnicy i jelita grubego oraz małoinwazyjnych operacjach odbytu z 15-letnim doświadczeniem. Członek International Society of University Colon and Rectal Surgeons, American Society of Abdominal Surgeons, American Surgical Association i European Society of Coloproctology.

Onkolog

Onkolog

Onkolog

Onkolog

Onkolog

Onkolog

Onkolog

Onkolog

Onkolog. Specjalista w leczeniu raka piersi